ReviewPharmaceuticals (Basel, Switzerland)2021

Empagliflozin-A New Chance for Patients with Chronic Heart Failure.

Klaudia Kowalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.